Amount Raised
$105 Million
Round Type
series b
Description
Third Harmonic Bio, a clinical-stage company, has raised $105 million in Series B funding.
Funding Insights
Based on industry dataTech investment trends
83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech